Home › Employers › Nucrogene Inc
Nucrogene Inc: H-1B salaries and sponsorship
Nucrogene Inc filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $61,994.
Does Nucrogene Inc sponsor H-1B visas?
Nucrogene Inc filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jan 28, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Formulation Chemist | 2 | $63,658 |
| Quality Control Chemist | 1 | $60,902 |
| Manufacturing Associate | 1 | $51,314 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 1 | $60,902 |
| FY2025 | 1 | $51,314 |
| FY2026 | 2 | $63,658 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Formulation Chemist | $64,230–$65,000 Level I | Branchburg, NJ | Jan 28, 2026 | Feb 5, 2026 | Certified |
| Manufacturing Associate | $51,314–$55,000 Level I | Branchburg, NJ | May 24, 2025 | Jun 25, 2025 | Certified |
| Formulation Chemist | $63,086–$65,000 Level I | Branchburg, NJ | May 23, 2025 | Jun 2, 2025 | Certified, then withdrawn |
| Quality Control Chemist | $60,902–$65,000 Level I | Branchburg, NJ | Jun 7, 2024 | Oct 1, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).